RB1 and cancer: Understanding the mechanisms that mediate the context dependent effect of Rb-inactivation, particularly in an in vivo system, will provide novel insights into the in vivo vulnerability of Rb mutant cells, which can potentially promote the development of novel therapeutic approaches to target cancers with inactivated Rb [9,10].